Zyneyro (private company)
See something wrong or missing? Let us know
Offices:Copenhagen
Industry:BiotechHealth servicesPharma
Business model:B2B
Zyneyro is a spin-out from the University of Copenhagen and Marigold Innovation, developing next-generation treatments for chronic pain without the current typical side effects.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 2.17M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Zyneyro
Name | Criteria | |
---|---|---|
![]() |
Athera
58%
|
|
![]() |
AttgeNO
58%
|
|
![]() |
Biotts
58%
|
|
![]() |
Oui
58%
|
|
![]() |
Pulmobiotics S.L
58%
|
|
![]() |
PEP-Therapy
58%
|
|
![]() |
Brinter
58%
|
|
![]() |
Colzyx
58%
|
|
![]() |
CimCure
58%
|
|
![]() |
Mable
58%
|
|